Skip to content

Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy

Investigation of Three Newly Developed 2-piece Convex Base-plates in Subjects With Ileostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01957397
Enrollment
26
Registered
2013-10-08
Start date
2012-10-31
Completion date
2012-12-31
Last updated
2016-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma

Brief summary

To investigate the performance and safety of the three 2-piece convex ostomy appliances

Interventions

Coloplast Test 1 is a newly developed 2-piece convex ostomy appliance

Coloplast Test 2 is a newly developed 2-piece convex ostomy appliance

DEVICEColoplast Test 3

Coloplast Test 3 is a newly developed 2-piece convex ostomy appliance

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects interested in participating in the clinical investigation must comply with the following criteria: 1. Are at least 18 years of age and have full legal capacity 2. Have had an ileostomy for at least 3 months. 3. Have used a convex ostomy appliance for the last month 4. Have given written informed consent 5. Have an ileostomy with a diameter of 33mm or less 6. Have experienced leakage (seeping) under the baseplate at least two times over the last two weeks

Exclusion criteria

Subjects complying with the following criteria must be excluded from participation in the clinical investigation: 1. Have a loop ostomy (also called double-barrel or ostomy with two outlets) 2. Are pregnant\* or breastfeeding. 3. Currently receiving, or have received within the last 2 months, chemotherapy or radiation therapy. 4. Currently receiving or have received, within the last month, systemic or local steroid treatment (adrenocortical hormone) in the peristomal area. 5. Currently suffering from peristomal skin problems (i.e. bleeding or broken skin (weeping skin)). 6. Known hypersensitivity toward any of the test products \-

Design outcomes

Primary

MeasureTime frameDescription
Degree of Leakage14 daysThe degree of leakage was measured with a 32 -point scale developed by Coloplast A/S, where 0 is the best possible outcome (no leakage) and 32 is the worst possible outcome (full leakage under the baseplate)

Countries

Denmark

Participant flow

Recruitment details

Subjects are recruited from the Coloplast A/S user database in Denmark.

Pre-assignment details

The subjects are randomised to two arms In both arms the subjects start measuring the performance of own product to collect baseline data. In this arm the subjects are randomised between Coloplast Test1 and Coloplast Test 2 In the third test period all subject test Coloplast Test 3

Participants by arm

ArmCount
Overall Population26
Total26

Withdrawals & dropouts

PeriodReasonFG000FG001
Test Period 1sudden leakage/small bag11
Test Period 1Withdrawal by Subject10
Test Period 2Adverse Event01
Test Period 3Adverse Event12
Test Period 3the adhesive did not work10

Baseline characteristics

CharacteristicOverall Population
Age, Continuous62.3 years
STANDARD_DEVIATION 10.4
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
7 / 2515 / 2412 / 223 / 26
serious
Total, serious adverse events
0 / 251 / 240 / 221 / 26

Outcome results

Primary

Degree of Leakage

The degree of leakage was measured with a 32 -point scale developed by Coloplast A/S, where 0 is the best possible outcome (no leakage) and 32 is the worst possible outcome (full leakage under the baseplate)

Time frame: 14 days

ArmMeasureValue (MEAN)Dispersion
Coloplast Test 1Degree of Leakage4.5 units on a scaleStandard Deviation 4.9
Coloplast Test 2Degree of Leakage5.2 units on a scaleStandard Deviation 4.8
Coloplast Test 3Degree of Leakage6.4 units on a scaleStandard Deviation 5.5
Baseline - Own ProductDegree of Leakage6.8 units on a scaleStandard Deviation 6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026